StudyFinder

EPI-MINN: Targeting Cognition and Motivation

Recruiting
I'm interested

All
15 Years to 40 Years old
This study is NOT accepting healthy volunteers
Inclusion Criteria:

• Enrolled in EPI-MINN: Measurement Based Care protocol, STUDY00009334
• Good general health (i.e. not acutely ill or experiencing a severe/chronic illness that would impede their ability to complete study activities. This determination shall be, if necessary, made at the discretion of the PIs)
• Estimated IQ at or above 70, as estimated by the Penn CNP Matrix Reasoning Test
• Achieved clinical stability, defined as outpatient status for at least one month prior to study participation and clinically stable doses of psychiatric medication (by PI discretion) for at least one month prior to study participation (including no medication)
• Has access to a smartphone or other mobile device to use the PRIME app
Exclusion Criteria:

• Under legal commitment to treatment or is under medical guardianship, and there is no provision in the guardianship order or a court order to allow the guardian to consent to participation in research
• Participated in significant cognitive training programs within the last three years
• Diagnosed with a neurological disorder (Autism Spectrum Disorder is allowed)
• Clinically significant substance abuse that is impeding the participant's abulity to participate fully during recruitment, enrollment, assessment, or training, (is unable to remain sober for assessments and training)
• Risk of suicidal behavior, as indicated by the clinicall obtained C-SSRS or clinician judgement. Risk of suicidal behavior is defined as:
• Active suicidal ideation at screening or baseline, or
• Previous intent to act on suicidal ideation with a specific plan, preparatory acts, or an actual suicide attempt within the last 3 months

Other: Cognitive and Social Cognitive Training, Device: Personalized Real-Time Motivational Enhancement (PRIME) App

Psychosis

Cognitive Training, Motivation Enhancement, First Episode Psychosis, Schizophrenia Spectrum Disorders

Sasha Mochida - epinetrct@umn.edu
Piper Myers-Kalos - psmeyer@umn.edu
N/A
NCT05112432
See this study on ClinicalTrials.gov

Back